BioNexus Gene Lab Corp
BGLC4.150USD
+0.050+1.22%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
7.46MMarket Cap
LossP/E TTM
More Details of BioNexus Gene Lab Corp Company
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
BioNexus Gene Lab Corp Info
Ticker SymbolBGLC
Company nameBioNexus Gene Lab Corp
IPO dateMar 11, 2020
CEOTan (Lee Su-Leng)
Number of employees30
Security typeOrdinary Share
Fiscal year-endMar 11
Address10-2 Tower B, Vertical Business Suite
CityKUALA LUMPUR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryMalaysia
Postal code59200
Phone13072416898
Websitehttps://www.bionexusgenelab.com/
Ticker SymbolBGLC
IPO dateMar 11, 2020
CEOTan (Lee Su-Leng)
Company Executives of BioNexus Gene Lab Corp
Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Other
63.04%
Shareholders
Shareholders
Proportion
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Other
63.04%
Shareholder Types
Shareholders
Proportion
Corporation
24.00%
Individual Investor
12.39%
Investment Advisor
0.94%
Other
62.67%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
14
22.28K
1.52%
--
2025Q3
14
22.28K
2.00%
+12.71K
2025Q2
13
9.56K
1.47%
-6.24K
2025Q1
13
15.80K
1.33%
-8.09K
2024Q4
12
17.81K
1.26%
+4.78K
2024Q3
9
13.03K
0.67%
+6.46K
2024Q2
7
6.57K
0.88%
-3.53K
2024Q1
7
10.10K
0.59%
-313.00
2023Q4
6
10.42K
1.15%
-9.94K
2023Q3
5
20.36K
0.00%
+20.36K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Liew (Choong-Chin)
166.67K
9.28%
--
--
Feb 27, 2025
Lai (Soo Kow(kenny))
125.00K
6.96%
--
--
Feb 27, 2025
UBS Financial Services, Inc.
9.56K
0.53%
+9.56K
--
Jun 30, 2025
Low (Jook Yuen)
1.26K
0.07%
--
--
Feb 27, 2025
Blackstone Alternative Investment Advisors LLC
3.00
0%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 03, 2025
Merger
10→1
Date
Type
Ratio
Apr 03, 2025
Merger
10→1
FAQs
Who are the top five shareholders of BioNexus Gene Lab Corp?
The top five shareholders of BioNexus Gene Lab Corp are:
Liew (Choong-Chin) holds 166.67K shares, accounting for 9.28% of the total shares.
Lai (Soo Kow(kenny)) holds 125.00K shares, accounting for 6.96% of the total shares.
UBS Financial Services, Inc. holds 9.56K shares, accounting for 0.53% of the total shares.
Low (Jook Yuen) holds 1.26K shares, accounting for 0.07% of the total shares.
Blackstone Alternative Investment Advisors LLC holds 3.00 shares, accounting for 0.00% of the total shares.
Liew (Choong-Chin) holds 166.67K shares, accounting for 9.28% of the total shares.
Lai (Soo Kow(kenny)) holds 125.00K shares, accounting for 6.96% of the total shares.
UBS Financial Services, Inc. holds 9.56K shares, accounting for 0.53% of the total shares.
Low (Jook Yuen) holds 1.26K shares, accounting for 0.07% of the total shares.
Blackstone Alternative Investment Advisors LLC holds 3.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of BioNexus Gene Lab Corp?
The top three shareholder types of BioNexus Gene Lab Corp are:
Fidelion Diagnostics Pte Ltd
ARC Group Ltd
Liew (Choong-Chin)
Fidelion Diagnostics Pte Ltd
ARC Group Ltd
Liew (Choong-Chin)
How many institutions hold shares of BioNexus Gene Lab Corp (BGLC)?
As of 2025Q4, 14 institutions hold shares of BioNexus Gene Lab Corp, with a combined market value of approximately 22.28K, accounting for 1.52% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.48%.
What is the biggest source of revenue for BioNexus Gene Lab Corp?
In --, the -- business generated the highest revenue for BioNexus Gene Lab Corp, amounting to -- and accounting for --% of total revenue.
